DCF — WINNESHIEK MEDICAL CENTER
Enterprise Value: $-17.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-17.1M
Enterprise Value
$-7.5M
PV of Cash Flows
$-9.6M
PV of Terminal Value
$-15.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $80.0M | $0.3M | 0.0% | $-3.1M | $-2.8M |
| Year 2 | $82.4M | $1.1M | 1.0% | $-2.3M | $-1.9M |
| Year 3 | $84.8M | $2.0M | 2.0% | $-1.6M | $-1.2M |
| Year 4 | $87.4M | $2.5M | 3.0% | $-1.3M | $-0.9M |
| Year 5 | $90.0M | $2.8M | 3.0% | $-1.1M | $-0.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-17.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$77.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.0011437155376289277
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5